{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:00:12Z","timestamp":1772136012347,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>EGFR<\/jats:italic>\n                    and\n                    <jats:italic>KRAS<\/jats:italic>\n                    are the most frequently mutated genes in lung cancer, being active research topics in targeted therapy. The biopsy is the traditional method to genetically characterise a tumour. However, it is a risky procedure, painful for the patient, and, occasionally, the tumour might be inaccessible. This work aims to study and debate the nature of the relationships between imaging phenotypes and lung cancer-related mutation status. Until now, the literature has failed to point to new research directions, mainly consisting of results-oriented works in a field where there is still not enough available data to train clinically viable models. We intend to open a discussion about critical points and to present new possibilities for future radiogenomics studies. We conducted high-dimensional data visualisation and developed classifiers, which allowed us to analyse the results for\n                    <jats:italic>EGFR<\/jats:italic>\n                    and\n                    <jats:italic>KRAS<\/jats:italic>\n                    biological markers according to different combinations of input features. We show that\n                    <jats:italic>EGFR<\/jats:italic>\n                    mutation status might be correlated to CT scans imaging phenotypes; however, the same does not seem to hold for\n                    <jats:italic>KRAS<\/jats:italic>\n                    mutation status. Also, the experiments suggest that the best way to approach this problem is by combining nodule-related features with features from other lung structures.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-60202-3","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T06:04:32Z","timestamp":1582783472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS"],"prefix":"10.1038","volume":"10","author":[{"given":"Gil","family":"Pinheiro","sequence":"first","affiliation":[]},{"given":"Tania","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Venceslau","family":"Hespanhol","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Luis","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"H\u00e9lder P.","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"60202_CR1","doi-asserted-by":"crossref","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer (2015).","DOI":"10.1002\/ijc.29210"},{"key":"60202_CR2","unstructured":"World Health Organisation. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. International Agency for Research on Cancer (2018)."},{"key":"60202_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0169-5002(00)00197-5","volume":"31","author":"ML Janssen-Heijnen","year":"2001","unstructured":"Janssen-Heijnen, M. L. & Coebergh, J.-W. W. Trends in incidence and prognosis of the histological subtypes of lung cancer in north america, australia, new zealand and europe. Lung cancer 31, 123\u2013137 (2001).","journal-title":"Lung cancer"},{"key":"60202_CR4","doi-asserted-by":"crossref","unstructured":"Rose-James, A. & Tt, S. Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer. Lung Cancer International (2012).","DOI":"10.1155\/2012\/729532"},{"key":"60202_CR5","doi-asserted-by":"crossref","unstructured":"Jorge, S. E., Kobayashi, S. S. & Costa, D. B. Epidermal growth factor receptor (EGFR) mutations in lung cancer: Preclinical and clinical data (2014).","DOI":"10.1590\/1414-431X20144099"},{"key":"60202_CR6","doi-asserted-by":"crossref","unstructured":"Harrison, P. T., Vyse, S. & Huang, P. H. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Seminars in Cancer Biology 1-13 (2019).","DOI":"10.1016\/j.semcancer.2019.09.015"},{"key":"60202_CR7","doi-asserted-by":"crossref","unstructured":"Ferrer, I. et al. KRAS-Mutant non-small cell lung cancer: From biology to therapy (2018).","DOI":"10.1016\/j.lungcan.2018.07.013"},{"key":"60202_CR8","doi-asserted-by":"crossref","unstructured":"Zhang, S. M. et al. Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: A systematic review and meta-analysis. Cancer Management and Research (2018).","DOI":"10.2147\/CMAR.S167578"},{"key":"60202_CR9","doi-asserted-by":"crossref","unstructured":"Fang, S. & Wang, Z. EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer (2014).","DOI":"10.2147\/DDDT.S69690"},{"key":"60202_CR10","doi-asserted-by":"crossref","unstructured":"Martin, P., Leighl, N. B., Tsao, M. S. & Shepherd, F. A. KRAS mutations as prognostic and predictive markers in non-small cell lung cancer (2013).","DOI":"10.1097\/JTO.0b013e318283d958"},{"key":"60202_CR11","doi-asserted-by":"crossref","unstructured":"Planchard, D. et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology (2018).","DOI":"10.1093\/annonc\/mdy275"},{"key":"60202_CR12","unstructured":"Lynch, T. J. et al. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib. New England Journal of Medicine (2004)."},{"key":"60202_CR13","doi-asserted-by":"crossref","unstructured":"Paez, J. G. et al. EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy. Science (2004).","DOI":"10.1126\/science.1099314"},{"key":"60202_CR14","unstructured":"Pao, W. et al. EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib. Proceedings of the National Academy of Sciences of the United States of America (2004)."},{"key":"60202_CR15","doi-asserted-by":"crossref","unstructured":"Schrank, Z. et al. Current molecular-targeted therapies in NSCLC and their mechanism of resistance (2018).","DOI":"10.3390\/cancers10070224"},{"key":"60202_CR16","doi-asserted-by":"crossref","unstructured":"Zhao, W. et al. Toward automatic prediction of EGFR mutation status in pulmonary adenocarcinoma with 3D deep learning. Cancer Medicine (2019).","DOI":"10.1002\/cam4.2233"},{"key":"60202_CR17","doi-asserted-by":"crossref","unstructured":"Tomasini, P., Walia, P., Labbe, C., Jao, K. & Leighl, N. B. Targeting the KRAS Pathway in Non-Small Cell Lung Cancer. The Oncologist (2016).","DOI":"10.1634\/theoncologist.2015-0084"},{"key":"60202_CR18","doi-asserted-by":"crossref","unstructured":"Canon, J. et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature (2019).","DOI":"10.1038\/s41586-019-1694-1"},{"key":"60202_CR19","doi-asserted-by":"crossref","unstructured":"Fakih, M. et al. Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of AMG 510, a novel small molecule KRAS G12C inhibitor, in advanced solid tumors. Journal of Clinical Oncology (2019).","DOI":"10.1200\/JCO.2019.37.15_suppl.3003"},{"key":"60202_CR20","doi-asserted-by":"publisher","first-page":"P711","DOI":"10.1016\/j.ebiom.2019.02.049","volume":"41","author":"H Adderley","year":"2019","unstructured":"Adderley, H., Blackhall, F. H. & Lindsay, C. R. KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition. EBioMedicine 41, P711\u2013716 (2019).","journal-title":"EBioMedicine"},{"key":"60202_CR21","doi-asserted-by":"crossref","unstructured":"Mullard, A. Cracking KRAS. Nature Reviews Drug Discovery (2019).","DOI":"10.1038\/d41573-019-00195-5"},{"key":"60202_CR22","unstructured":"Folch, E., Costa, D. B., Wright, J. & VanderLaan, P. A. Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis (2015)."},{"key":"60202_CR23","doi-asserted-by":"crossref","unstructured":"Jain, E. & Roy-Chowdhuri, S. Molecular pathology of lung cancer cytology specimens a concise review (2018).","DOI":"10.5858\/arpa.2017-0444-RA"},{"key":"60202_CR24","doi-asserted-by":"crossref","unstructured":"Cai, L. L. & Wang, J. Liquid biopsy for lung cancer immunotherapy (Review) (2019).","DOI":"10.3892\/ol.2019.10166"},{"key":"60202_CR25","doi-asserted-by":"crossref","unstructured":"Rizzo, S. et al. CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer. European Radiology (2016).","DOI":"10.1007\/s00330-015-3814-0"},{"key":"60202_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.202","volume":"5","author":"S Bakr","year":"2018","unstructured":"Bakr, S. et al. A radiogenomic dataset of non-small cell lung cancer. Scientific data 5, 180202 (2018).","journal-title":"Scientific data"},{"key":"60202_CR27","doi-asserted-by":"crossref","unstructured":"Bodalal, Z., Trebeschi, S., Nguyen-Kim, T. D. L., Schats, W. & Beets-Tan, R. Radiogenomics: bridging imaging and genomics (2019).","DOI":"10.1007\/s00261-019-02028-w"},{"key":"60202_CR28","doi-asserted-by":"crossref","unstructured":"Digumarthy, S. R., Padole, A. M., Gullo, R. L., Sequist, L. V. & Kalra, M. K. Can ct radiomic analysis in nsclc predict histology and egfr mutation status? Medicine 98 (2019).","DOI":"10.1097\/MD.0000000000013963"},{"key":"60202_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-018-0184-2","volume":"18","author":"D Mei","year":"2018","unstructured":"Mei, D., Luo, Y., Wang, Y. & Gong, J. Ct texture analysis of lung adenocarcinoma: can radiomic features be surrogate biomarkers for egfr mutation statuses. Cancer Imaging 18, 52 (2018).","journal-title":"Cancer Imaging"},{"key":"60202_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cllc.2016.02.001","volume":"17","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Radiomic features are associated with egfr mutation status in lung adenocarcinomas. Clinical lung cancer 17, 441\u2013448 (2016).","journal-title":"Clinical lung cancer"},{"key":"60202_CR31","doi-asserted-by":"crossref","unstructured":"Wang, S. et al. Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning. European Respiratory Journal (2019).","DOI":"10.1183\/13993003.00986-2018"},{"key":"60202_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep41674","volume":"7","author":"O Gevaert","year":"2017","unstructured":"Gevaert, O. et al. Predictive radiogenomics modeling of egfr mutation status in lung cancer. Scientific reports 7, 41674 (2017).","journal-title":"Scientific reports"},{"key":"60202_CR33","doi-asserted-by":"crossref","unstructured":"Dias, C., Pinheiro, G., Cunha, A. & Oliveira, H. P. Radiogenomics: Lung Cancer-Related Genes Mutation Status Prediction. In IbPRIA 2019: 9th Iberian Conference on Pattern Recognition and Image Analysis (2019).","DOI":"10.1007\/978-3-030-31321-0_29"},{"key":"60202_CR34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","volume":"26","author":"K Clark","year":"2013","unstructured":"Clark, K. et al. The cancer imaging archive (tcia): Maintaining and operating a public information repository. Journal of Digital Imaging 26, 1045\u20131057 (2013).","journal-title":"Journal of Digital Imaging"},{"key":"60202_CR35","doi-asserted-by":"crossref","unstructured":"Gevaert, O. et al. Non-small cell lung cancer: Identifying prognostic imaging biomarkers by leveraging public gene expression microarray data - Methods and preliminary results. Radiology (2012).","DOI":"10.1148\/radiol.12111607"},{"key":"60202_CR36","doi-asserted-by":"crossref","unstructured":"Shen, S., Han, S. X., Bui, A. A. & Hsu, W. An interpretable deep hierarchical semantic convolutional neural network for lung nodule malignancy classification. Expert Systems with Applications (2019).","DOI":"10.1016\/j.eswa.2019.01.048"},{"key":"60202_CR37","doi-asserted-by":"crossref","unstructured":"Mei, D., Luo, Y., Wang, Y. & Gong, J. CT texture analysis of lung adenocarcinoma: Can Radiomic features be surrogate biomarkers for EGFR mutation statuses. Cancer Imaging (2018).","DOI":"10.1186\/s40644-018-0184-2"},{"key":"60202_CR38","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3892\/ol.2015.3600","volume":"10","author":"E Papadopoulou","year":"2015","unstructured":"Papadopoulou, E. et al. Determination of egfr and kras mutational status in greek non-small-cell lung cancer patients. Oncology letters 10, 2176\u20132184 (2015).","journal-title":"Oncology letters"},{"key":"60202_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/JTO.0b013e31827914ea","volume":"8","author":"AM Varghese","year":"2013","unstructured":"Varghese, A. M. et al. Lungs don\u2019t forget: comparison of the kras and egfr mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers. Journal of Thoracic Oncology 8, 123\u2013125 (2013).","journal-title":"Journal of Thoracic Oncology"},{"key":"60202_CR40","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1158\/1078-0432.CCR-11-3265","volume":"18","author":"S Dogan","year":"2012","unstructured":"Dogan, S. et al. Molecular epidemiology of egfr and kras mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related kras-mutant cancers. Clinical cancer research 18, 6169\u20136177 (2012).","journal-title":"Clinical cancer research"},{"key":"60202_CR41","unstructured":"Yip, S. S. et al. Associations between somatic mutations and metabolic imaging phenotypes in non-small cell lung cancer. Journal of Nuclear Medicine (2017)."},{"key":"60202_CR42","doi-asserted-by":"crossref","unstructured":"Yip, S. S. et al. Impact of experimental design on PET radiomics in predicting somatic mutation status. European Journal of Radiology (2017).","DOI":"10.1016\/j.ejrad.2017.10.009"},{"key":"60202_CR43","doi-asserted-by":"crossref","unstructured":"Zhang, H., Cai, W., Wang, Y., Liao, M. & Tian, S. CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis. International Journal of Clinical Oncology (2019).","DOI":"10.1007\/s10147-019-01403-3"},{"key":"60202_CR44","doi-asserted-by":"crossref","unstructured":"Hosny, A. et al. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study. PLoS Medicine (2018).","DOI":"10.1371\/journal.pmed.1002711"},{"key":"60202_CR45","doi-asserted-by":"crossref","unstructured":"Wilson, R. & Devaraj, A. Radiomics of pulmonary nodules and lung cancer (2017).","DOI":"10.21037\/tlcr.2017.01.04"},{"key":"60202_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s13244-018-0639-9","volume":"9","author":"R Yamashita","year":"2018","unstructured":"Yamashita, R., Nishio, M., Kinh, R., Do, G. & Togashi, K. Convolutional neural networks : an overview and application in radiology. Insights Imaging 9, 611\u2013629 (2018).","journal-title":"Insights Imaging"},{"key":"60202_CR47","unstructured":"Davidson, M. R., Gazdar, A. F. & Clarke, B. E. The pivotal role of pathology in the management of lung cancer (2013)."},{"key":"60202_CR48","doi-asserted-by":"crossref","unstructured":"Doshi, J. A., Hendrick, F. B., Graff, J. S. & Stuart, B. C. Data, Data Everywhere, But Access Remains a Big Issue for Researchers: A Review of Access Policies for Publicly-Funded Patient-level Health Care Data in the United States. eGEMs (Generating Evidence & Methods to improve patient outcomes) (2016).","DOI":"10.13063\/2327-9214.1204"},{"key":"60202_CR49","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jacr.2007.06.004","volume":"4","author":"CE Kahn","year":"2007","unstructured":"Kahn, C. E., Carrino, J. A., Flynn, M. J., Peck, D. J. & Horii, S. C. Dicom and radiology: past, present, and future. Journal of the American College of Radiology 4, 652\u2013657 (2007).","journal-title":"Journal of the American College of Radiology"},{"key":"60202_CR50","doi-asserted-by":"crossref","unstructured":"Bakr, S. et al. Data descriptor: A radiogenomic dataset of non-small cell lung cancer. Scientific Data (2018).","DOI":"10.1038\/sdata.2018.202"},{"key":"60202_CR51","doi-asserted-by":"crossref","unstructured":"Kalra, A. Developing fe human models from medical images. In Yang, K.-H. (ed.) Basic Finite Element Method as Applied to Injury Biomechanics (2018).","DOI":"10.1016\/B978-0-12-809831-8.00009-X"},{"key":"60202_CR52","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1556-4029.2009.01100.x","volume":"54","author":"SA Bolliger","year":"2009","unstructured":"Bolliger, S. A., Oesterhelweg, L., Spendlove, D., Ross, S. & Thali, M. J. Is differentiation of frequently encountered foreign bodies in corpses possible by hounsfield density measurement? Journal of forensic sciences 54, 1119\u20131122 (2009).","journal-title":"Journal of forensic sciences"},{"key":"60202_CR53","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJ Van Griethuysen","year":"2017","unstructured":"Van Griethuysen, J. J. et al. Computational radiomics system to decode the radiographic phenotype. Cancer research 77, e104\u2013e107 (2017).","journal-title":"Cancer research"},{"key":"60202_CR54","doi-asserted-by":"crossref","unstructured":"Prochazka, A., Grafova, L., Vy\u0161ata, O. & Caregroup, N. Three-dimensional wavelet transform in multi-dimensional biomedical volume processing. In Proc. of the IASTED International Conference on Graphics and Virtual Reality, Cambridge, 263\u2013268 (2011).","DOI":"10.2316\/P.2011.741-010"},{"key":"60202_CR55","doi-asserted-by":"crossref","unstructured":"Fotin, S. V., Reeves, A. P., Biancardi, A. M., Yankelevitz, D. F. & Henschke, C. I. A multiscale laplacian of gaussian filtering approach to automated pulmonary nodule detection from whole-lung low-dose ct scans. In Medical Imaging 2009: Computer-Aided Diagnosis, vol. 7260, 72601Q (International Society for Optics and Photonics, 2009).","DOI":"10.1117\/12.811420"},{"key":"60202_CR56","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell, D. M. et al. Fleischner society: glossary of terms for thoracic imaging. Radiology 246, 697\u2013722 (2008).","journal-title":"Radiology"},{"key":"60202_CR57","unstructured":"Abdi, H. and Williams, L. J. Principal component analysis. In Encyclopedia of Biometrics (2009)."},{"key":"60202_CR58","first-page":"2579","volume":"9","author":"Lvd Maaten","year":"2008","unstructured":"Maaten, L. v. d. & Hinton, G. Visualizing data using t-sne. Journal of machine learning research 9, 2579\u20132605 (2008).","journal-title":"Journal of machine learning research"},{"key":"60202_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla, N. V., Bowyer, K. W., Hall, L. O. & Kegelmeyer, W. P. Smote: synthetic minority over-sampling technique. Journal of artificial intelligence research 16, 321\u2013357 (2002).","journal-title":"Journal of artificial intelligence research"},{"key":"60202_CR60","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. XGBoost: A scalable tree boosting system. In Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (2016).","DOI":"10.1145\/2939672.2939785"},{"key":"60202_CR61","doi-asserted-by":"crossref","unstructured":"Nishio, M. et al. Computer-aided diagnosis of lung nodule using gradient tree boosting and Bayesian optimization. PLoS ONE (2018).","DOI":"10.1371\/journal.pone.0195875"},{"key":"60202_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2019.00001","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Identification of Cancer-Related Long Non-Coding RNAs Using XGBoost With High Accuracy. Front. Genet. 10, 1\u201314 (2019).","journal-title":"Front. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60202-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60202-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60202-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:20:44Z","timestamp":1670293244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60202-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60202"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60202-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/794123","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"21 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3625"}}